Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rapport Therapeutics Inc....

    NASDAQ: RAPP · Real-Time Price · USD
    14.66
    -0.28 (-1.87%)
    At close: Aug 15, 2025, 3:59 PM
    14.57
    -0.61%
    After-hours: Aug 15, 2025, 05:51 PM EDT

    Rapport Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 720K 720K 720K n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 715K 671K 579K 655K 436K 249K 112K 36K 36K 15K
    Gross Profit
    		 -355K -311K -219K -655K -436K -249K -112K -36K -36K -15K
    Operating Income
    		 -101.77M -93.07M -83.06M -74.33M -62.25M -48.08M -36.18M -21.39M -11.82M -5.19M
    Interest Income
    		 13.45M 13.37M 12.14M 9.97M 6.72M 4.27M 2.53M 1.15M 296K 75K
    Pretax Income
    		 -88.31M -79.7M -78.31M -71.84M -63.01M -51.3M -34.78M -21.26M -12.55M -6.15M
    Net Income
    		 -88.31M -79.7M -78.31M -71.85M -63.02M -51.31M -34.79M -21.27M -12.56M -6.15M
    Selling & General & Admin
    		 26.77M 24.86M 21.76M 18.36M 14.24M 11.23M 8.07M 5.15M 3.17M 1.28M
    Research & Development
    		 74.99M 68M 60.94M 55.53M 47.57M 36.6M 28M 16.2M 8.62M 3.9M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 101.77M 92.86M 82.69M 73.89M 61.82M 47.83M 36.07M 21.35M 11.79M 5.18M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a -208K -360K -436K -436K -249K -112K -36K -36K -15K
    Cost & Expenses
    		 101.77M 93.07M 83.06M 74.33M 62.25M 48.08M 36.18M 21.39M 11.82M 5.19M
    Income Tax Expense
    		 n/a n/a n/a 6K 7K 9K 10K 4K 3K 1K
    Shares Outstanding (Basic)
    		 354.45M 192.88M 192.88M 191.71M 201.17M 194.57M 180.79M 190.98M 201.17M 194.57M
    Shares Outstanding (Diluted)
    		 354.45M 192.88M 192.88M 191.71M 201.17M 194.57M 180.79M 190.98M 201.17M 194.57M
    EPS (Basic)
    		 -1.06 -0.4 -0.4 -0.38 -0.33 -0.27 -0.18 -0.11 -0.06 -0.03
    EPS (Diluted)
    		 -1.06 -0.4 -0.4 -0.38 -0.33 -0.27 -0.18 -0.11 -0.06 -0.03
    EBITDA
    		 -101.29M -92.38M -82.22M -72.29M -60.41M -46.43M -34.66M -21.33M -11.79M -5.18M
    EBIT
    		 -95.96M -90.02M -83.06M -72.92M -60.85M -46.68M -34.78M -21.39M -11.82M -5.19M
    Depreciation & Amortization
    		 723K 931K 839K 632K 436K 249K 112K 59K 36K 15K

    Add to Watchlist